TipRanks
Generate Biomedicines, Inc. (GENB)
NASDAQ:GENB
US Market
GENB
Generate Biomedicines, Inc.
RESEARCH TOOLSreports
Want to see GENB full AI Analyst Report?

Generate Biomedicines, Inc. (GENB) Income Statement

149 Followers

Generate Biomedicines, Inc. Income Statement

Last quarter (Q2 2026), Generate Biomedicines, Inc.'s total revenue was $6.31M, a decrease of -12.60% from previous quarter. In Q2, Generate Biomedicines, Inc.'s net income was $-67.25M. See Generate Biomedicines, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24
Total Revenue
$ 31.89M$ 20.46M
Gross Profit
$ 31.89M$ 20.46M
Operating Expenses
$ 266.96M$ 217.40M
Depreciation and Amortization
$ 13.18M$ 15.35M
EBITDA
$ -208.49M$ -163.71M
Operating Income
$ -235.06M$ -196.94M
Other Income/Expenses
$ 12.26M$ 15.77M
Pretax Income
$ -222.80M$ -181.17M
Net Income
$ -203.15M$ -173.77M
Per Share Metrics
Basic EPS
$ -4.98$ -1.68
Diluted EPS
$ -4.98$ -1.68
Weighted Average Shares Outstanding
 50.09M 127.45M
Weighted Average Shares Outstanding (Diluted)
 50.09M 127.45M
Currency in USD

Generate Biomedicines, Inc. Earnings and Revenue History